1-2 of 2
Edward Pequignot
Close
Sort by
Journal Articles

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

Clinical Trials & Observations
Saar Gill, Vanessa Vides, Noelle V. Frey, Elizabeth O. Hexner, Susan Metzger, Megan O'Brien, Wei-Ting Hwang, Jennifer L. Brogdon, Megan M. Davis, Joseph A. Fraietta, Avery L. Gaymon, Whitney L. Gladney, Simon F. Lacey, Anne Lamontagne, Anthony R. Mato, Marcela V. Maus, J. Joseph Melenhorst, Edward Pequignot, Marco Ruella, Maksim Shestov, John C. Byrd, Stephen J. Schuster, Donald L. Siegel, Bruce L. Levine, Carl H. June, David L. Porter
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5774–5785.
https://doi.org/10.1182/bloodadvances.2022007317
Published: 2022
Includes: Supplemental data
Journal Articles

Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children

Clinical Trials & Observations
Caroline Diorio, Pamela A. Shaw, Edward Pequignot, Alena Orlenko, Fang Chen, Richard Aplenc, David M. Barrett, Hamid Bassiri, Edward Behrens, Amanda M. DiNofia, Vanessa Gonzalez, Natalka Koterba, Bruce L. Levine, Shannon L. Maude, Nuala J. Meyer, Jason H. Moore, Michele Paessler, David L. Porter, Jenny L. Bush, Don L. Siegel, Megan M. Davis, Donglan Zhang, Carl H. June, Stephan A. Grupp, J. Joseph Melenhorst, Simon F. Lacey, Scott L. Weiss, David T. Teachey
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5174–5183.
https://doi.org/10.1182/bloodadvances.2020002592
Published: 2020
Includes: Supplemental data